A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

Clinical trial NCT06674577 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06674577
Sponsor: Vera Therapeutics, Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

IgA Nephropathy (IgAN)Renal and Urinary Disorders Berger Disease

Start date: 2024-12-01
Primary completion: 2031-05-21
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.